111 related articles for article (PubMed ID: 17611403)
21. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
22. Activation of the early growth response 1 gene and nuclear pp90rsk in human myeloid leukemia cells by 1-(beta-D-arabinofuranosyl)cytosine.
Kharbanda S; Saleem A; Rubin E; Sukhatme V; Blenis J; Kufe D
Biochemistry; 1993 Sep; 32(35):9137-42. PubMed ID: 7690249
[TBL] [Abstract][Full Text] [Related]
23. p53 Binding to the p21 promoter is dependent on the nature of DNA damage.
Hill R; Bodzak E; Blough MD; Lee PW
Cell Cycle; 2008 Aug; 7(16):2535-43. PubMed ID: 18719376
[TBL] [Abstract][Full Text] [Related]
24. GADD45α-targeted suicide gene therapy driven by synthetic CArG promoter E9NS sensitizes NSCLC cells to cisplatin, resveratrol, and radiation regardless of p53 status.
Shi Q; Sutariya V; Varghese Gupta S; Bhatia D
Onco Targets Ther; 2019; 12():3161-3170. PubMed ID: 31114253
[No Abstract] [Full Text] [Related]
25. Differential regulation of the p21/WAF-1 and mdm2 genes after high-dose UV irradiation: p53-dependent and p53-independent regulation of the mdm2 gene.
Wu L; Levine AJ
Mol Med; 1997 Jul; 3(7):441-51. PubMed ID: 9260156
[TBL] [Abstract][Full Text] [Related]
26. The radiation-inducible pE9 promoter driving inducible nitric oxide synthase radiosensitizes hypoxic tumour cells to radiation.
Coulter JA; McCarthy HO; Worthington J; Robson T; Scott S; Hirst DG
Gene Ther; 2008 Apr; 15(7):495-503. PubMed ID: 18256696
[TBL] [Abstract][Full Text] [Related]
27. Tissue specificity of L-pyruvate kinase transgenes results from the combinatorial effect of proximal promoter and distal activator regions.
Miquerol L; Cluzeaud F; Porteu A; Alexandre Y; Vandewalle A; Kahn A
Gene Expr; 1996; 5(6):315-30. PubMed ID: 8836739
[TBL] [Abstract][Full Text] [Related]
28. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation.
Kawashita Y; Ohtsuru A; Kaneda Y; Nagayama Y; Kawazoe Y; Eguchi S; Kuroda H; Fujioka H; Ito M; Kanematsu T; Yamashita S
Hum Gene Ther; 1999 Jun; 10(9):1509-19. PubMed ID: 10395376
[TBL] [Abstract][Full Text] [Related]
29. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional regulation of the tissue-type plasminogen-activator gene in human endothelial cells: identification of nuclear factors that recognise functional elements in the tissue-type plasminogen-activator gene promoter.
Costa M; Shen Y; Maurer F; Medcalf RL
Eur J Biochem; 1998 Nov; 258(1):123-31. PubMed ID: 9851700
[TBL] [Abstract][Full Text] [Related]
31. Cell-type specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitro.
Arts J; Herr I; Lansink M; Angel P; Kooistra T
Nucleic Acids Res; 1997 Jan; 25(2):311-7. PubMed ID: 9016559
[TBL] [Abstract][Full Text] [Related]
32. Enhanced EJ Cell Killing of (125)I Radiation by Combining with Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive Promoter.
Li L; Zhang CL; Kang L; Wang RF; Yan P; Zhao Q; Yin L; Guo FQ
Cancer Biother Radiopharm; 2015 Oct; 30(8):342-8. PubMed ID: 26382009
[TBL] [Abstract][Full Text] [Related]
33. Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin.
Greco O; Powell TM; Marples B; Joiner MC; Scott SD
Cancer Gene Ther; 2005 Jul; 12(7):655-62. PubMed ID: 15818381
[TBL] [Abstract][Full Text] [Related]
34. Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter.
Zhang P; Tchou-Wong KM; Costa M
Cancer Res; 2007 Oct; 67(19):9125-33. PubMed ID: 17909017
[TBL] [Abstract][Full Text] [Related]
35. [Anti-tumor effect of suicide gene therapy using chimeric promoter plus radiotherapy on cancer cell lines].
Sun WJ; Xiong J; Wang WF; Liao ZK; Zhou FX; Zhou YF
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):245-50. PubMed ID: 21575492
[TBL] [Abstract][Full Text] [Related]
36. Involvement of Oct-1 in the regulation of CDKN1A in response to clinically relevant doses of ionizing radiation.
Nenoi M; Daino K; Nakajima T; Wang B; Taki K; Kakimoto A
Biochim Biophys Acta; 2009 Mar; 1789(3):225-31. PubMed ID: 19118657
[TBL] [Abstract][Full Text] [Related]
37. Control elements between -9.5 and -3.0 kb in the human tissue-type plasminogen activator gene promoter direct spatial and inducible expression to the murine brain.
Yu H; Schleuning WD; Michl M; Liberatore G; Tan SS; Medcalf RL
Eur J Neurosci; 2001 Sep; 14(5):799-808. PubMed ID: 11576184
[TBL] [Abstract][Full Text] [Related]
38. NF-kappaB and AP-1 are responsible for inducibility of the IL-6 promoter by ionizing radiation in HeLa cells.
Beetz A; Peter RU; Oppel T; Kaffenberger W; Rupec RA; Meyer M; van Beuningen D; Kind P; Messer G
Int J Radiat Biol; 2000 Nov; 76(11):1443-53. PubMed ID: 11098847
[TBL] [Abstract][Full Text] [Related]
39. Microarray analysis of p53-dependent gene expression in response to hypoxia and DNA damage.
Corn PG; El-Deiry WS
Cancer Biol Ther; 2007 Dec; 6(12):1858-66. PubMed ID: 18087215
[TBL] [Abstract][Full Text] [Related]
40. Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs.
Naoum GE; Zhu ZB; Buchsbaum DJ; Curiel DT; Arafat WO
Clin Transl Med; 2017 Dec; 6(1):11. PubMed ID: 28251571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
